keyword
https://read.qxmd.com/read/38590856/design-synthesis-and-in-silico-molecular-docking-evaluation-of-novel-1-2-3-triazole-derivatives-as-potent-antimicrobial-agents
#21
JOURNAL ARTICLE
Sudhakar Reddy Baddam, Mahesh Kumar Avula, Raghunadh Akula, Venkateswara Rao Battula, Sudhakar Kalagara, Ravinder Buchikonda, Srinivas Ganta, Srinivasadesikan Venkatesan, Tejeswara Rao Allaka
Chalcone and triazole scaffolds have demonstrated a crucial role in the advancement of science and technology. Due to their significance, research has proceeded on the design and development of novel benzooxepine connected to 1,2,3-triazolyl chalcone structures. The new chalcone derivatives produced by benzooxepine triazole methyl ketone 2 and different aromatic carbonyl compounds 3 are discussed in this paper. All prepared compounds have well-established structures to a variety of spectral approaches, including mass analysis, 1 H NMR, 13 C NMR, and IR...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38590504/once-weekly-liposomal-amphotericin-b-use-for-maintenance-and-consolidation-phase-treatment-of-cryptococcal-meningitis-in-patients-with-aids
#22
Vadim Belinschi, Charity Iheagwara, Ala Muhanna
Cryptococcal meningitis should be considered in individuals diagnosed with human immunodeficiency virus (HIV) infection and presenting with a cluster of differentiation 4 (CD4)-helper T cell count below 100 cells/ml. The 2022 guidelines from the World Health Organization (WHO) advocate for initiating treatment with a high dose (10 mg/kg) of liposomal amphotericin B, followed by flucytosine and fluconazole for a two-week duration. Additionally, alternative treatment options involving a combination of flucytosine and fluconazole are recommended...
March 2024: Curēus
https://read.qxmd.com/read/38589765/exploring-the-therapeutic-potential-of-scorpion-derived-css54-peptide-against-candida-albicans
#23
JOURNAL ARTICLE
Jonggwan Park, Hyeongsun Kim, Da Dam Kang, Yoonkyung Park
Candida albicans (C. albicans) is one of the most common opportunistic fungi worldwide, which is associated with a high mortality rate. Despite treatment, C. albicans remains the leading cause of life-threatening invasive infections. Consequently, antimicrobial peptides (AMPs) are potential alternatives as antifungal agents with excellent antifungal activity. We previously reported that Css54, found in the venom of Centrurodies suffusus suffusus (C. s. suffusus) showed antibacterial activity against zoonotic bacteria...
April 8, 2024: Journal of Microbiology / the Microbiological Society of Korea
https://read.qxmd.com/read/38587347/-tomography-guided-biopsy-for-the-diagnosis-of-pediatric-pulmonary-cryptococcosis
#24
JOURNAL ARTICLE
Juan José Bosch Fragueiro, María Macarena Iudica
UNLABELLED: Pulmonary cryptococcosis is a lung infection caused by the Cryptococcus yeast. It is rare in pediatrics, especially in immunocompetent children. The diagnosis of pulmonary cryptococcosis can be challenging due to the low specificity of symptoms, low index of suspicion, and limited diagnostic resources. OBJECTIVE: To describe a clinical case of pulmonary cryptococcosis in an immunocompetent adolescent, detailing the diagnostic approach. CLINICAL CASE: A 15-year-old patient, previously healthy, from a rural town, who consulted due to cough and a 1-month rib stitch pain, without fever or associated respiratory difficulty, with two images of condensation in the left lung on the chest x-ray...
February 2024: Andes pediatrica: revista Chilena de pediatría
https://read.qxmd.com/read/38585804/achieving-resilience-in-aging-how-mitochondrial-modulation-drives-age-associated-fluconazole-tolerance-in-cryptococcus-neoformans
#25
Kyungyoon Yoo, Natalia Kronbauer Oliveira, Somanon Bhattacharya, Bettina C Fries
UNLABELLED: Cryptococcus neoformans ( Cn ) is an opportunistic fungal microorganism that causes life-threatening meningoencephalitis. During the infection, the microbial population is heterogeneously composed of cells with varying generational ages, with older cells accumulating during chronic infections. This is attributed to their enhanced resistance to phagocytic killing and tolerance of antifungals like fluconazole (FLC). In this study, we investigated the role of ergosterol synthesis, ATP-binding cassette (ABC) transporters, and mitochondrial metabolism in the regulation of age-dependent FLC tolerance...
March 26, 2024: bioRxiv
https://read.qxmd.com/read/38584605/evaluating-cardiac-disorders-associated-with-triazole-antifungal-agents-based-on-the-us-food-and-drug-administration-adverse-event-reporting-system-database
#26
JOURNAL ARTICLE
Jinhua Chen, Shijun Xu, Weijiang Yu, Cuicui Sun, Wenzhou Zhang
INTRODUCTION: Triazole antifungal agents are widely used to treat and prevent systemic mycoses. With wide clinical use, the number of reported adverse events has gradually increased. The aim of this study was to analyze the cardiac disorders associated with TAAs (fluconazole, voriconazole, itraconazole, posaconazole and isavuconazole) based on data from the US Food and Drug Administration Adverse Event Reporting System FDA Adverse Event Reporting System. METHODS: Data were extracted from the FAERS database between the first quarter of 2004 and third quarter of 2022...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38584320/low-toxicity-contributes-to-sporothrix-globosa-invade-the-skin-of-patients-in-low-epidemic-areas-of-china
#27
JOURNAL ARTICLE
Yuying Qu, Yahui Feng, Shaodong Bian, Yang Yang, Dongmei Li, Weida Liu, Dongmei Shi
OBJECTIVE: This study aims to assess the clinical characteristics of sporotrichosis in low-endemic areas of China, including the prevalence geography, genotypic traits of patients, clinical manifestations, and strain virulence and drug sensitivities. The objective is to improve the currently used clinical management strategies for sporotrichosis. METHODS: Retrospective data were collected from patients diagnosed with sporotrichosis through fungal culture identification...
April 2024: Mycoses
https://read.qxmd.com/read/38582029/synergistic-activity-of-crocin-and-crocin-loaded-in-niosomes-alone-and-in-combination-with-fluconazole-against-candida-albicans-isolates-in-vitro-and-in-silico-study
#28
JOURNAL ARTICLE
Sara Norozipor, Mehdi Bamorovat, Seyyed Amin Ayatollahi Mosavi, Ehsan Salarkia, Sanaz Hadizadeh, Fatemeh Sharifi, Ali Karamoozian, Mehdi Ranjbar, Setareh Agha Kuchak Afshari
INTRODUCTION: Since the drug resistance in Candida species is becoming a serious clinical challenge, novel alternative therapeutic options, particularly herbal medicine, have attracted increasing interest. This study aimed to pinpoint the potential antifungal activity of crocin (Cro), the efficacy of the niosomal formulation of Cro (NCro), and the synergistic activity of both formulations in combination with fluconazole (FLC) against susceptible and resistant C. albicans isolates. MATERIAL AND METHODS: NCro was formulated using the heating method...
April 3, 2024: Journal de Mycologie Médicale
https://read.qxmd.com/read/38574764/clinico-mycological-and-therapeutic-updates-on-tinea-corporis-cruris-in-the-era-of-trichophyton-indotineae
#29
REVIEW
A Khurana, S Savitha, K Sardana, A Chowdhary
Trichophyton indotineae (TI) has emerged as a novel dermatophyte species causing treatment recalcitrant skin infections. While the earliest reports came from India, TI has now spread to many parts of the world and is rapidly becoming a global health concern. Accurate identification of TI requires elaborate mycological investigations not in the domain of routine microbiology laboratories. Extensive, non-inflammatory and atypical presentations are commonly seen with this novel species. TI shows an alarmingly high rate of mutations in the squalene epoxidase gene leading to lowered invitro susceptibility to terbinafine...
April 2, 2024: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/38574412/candida-auris-in-greek-healthcare-facilities-active-surveillance-results-on-first-cases-and-outbreaks-from-eleven-hospitals-within-attica-region
#30
JOURNAL ARTICLE
Lida Politi, Georgia Vrioni, Sofia Hatzianastasiou, Malvina Lada, Maria Martsoukou, Nikolaos V Sipsas, Maria Chini, Vasiliki Baka, Eleni Kafkoula, Aikaterini Masgala, Maria Pirounaki, Christos Michailidis, Georgios Chrysos, Olympia Zarkotou, Vasiliki Mamali, Vasileios Papastamopoulos, Georgios Saroglou, Spyros Pournaras, Joseph Meletiadis, Ioannis Karakasiliotis, Stefanos Karachalios, Stavroula Smilakou, Vasiliki Skandami, Maria Orfanidou, Athina Argyropoulou, Athanassios Tsakris, Flora Kontopidou
BACKGROUND: Candida auris was sporadically detected in Greece until 2019. Thereupon, there has been an increase in isolations among inpatients of healthcare facilities. AIM: We aim to report active surveillance data on MALDI-TOF confirmed Candida auris cases and outbreaks, from November 2019 to September 2021. METHODS: A retrospective study on hospital-based Candida auris data, over a 23-month period was conducted, involving 11 hospitals within Attica region...
March 26, 2024: Journal de Mycologie Médicale
https://read.qxmd.com/read/38571832/cryptococcosis-and-cryptococcal-meningitis-a-narrative-review-and-the-up-to-date-management-approach
#31
REVIEW
Zaheer A Qureshi, Haider Ghazanfar, Faryal Altaf, Ali Ghazanfar, Khushbu Z Hasan, Sameer Kandhi, Ked Fortuzi, Arundhati Dileep, Shitij Shrivastava
Cryptococcosis is a fungal infectious disease that enormously impacts human health worldwide. Cryptococcal meningitis is the most severe disease caused by the fungus Cryptococcus, and can lead to death, if left untreated. Many patients develop resistance and progress to death even after treatment. It requires a prolonged treatment course in people with AIDS. This narrative review provides an evidence-based summary of the current treatment modalities and future trial options, including newer ones, namely, 18B7, T-2307, VT-1598, AR12, manogepix, and miltefosine...
March 2024: Curēus
https://read.qxmd.com/read/38568411/efficacy-and-safety-of-oral-ibrexafungerp-in-chinese-patients-with-vulvovaginal-candidiasis-a-phase-iii-randomized-double-blind-study
#32
JOURNAL ARTICLE
Xiaoqian Wang, Wenying Wang, Jingjing Li, Ruifang An, Lihong Chen, Jiajing Lin, Dabao Xu, Jin Qiu, Weihua Song, Mijiti Patiman, Hongjie Ruan, Gang Wang, Fengxia Xue, Xu Wang, Xiaowan Luo, Qi Ruan, Ling Shi, Chun Zhang, Lina Hu, Shijin Wang, Hong Shi, Xiaoli Wang, Songling Zhang, Yingxiong Li, Jing Lu, Baojin Wang, Hongyan Xu, Hong Ye, Bei Zhang, Chunlian Zhang, Sumin Qian, Qiong Wu, Wen Jia, Chuan Li, Qinping Liao
PURPOSE: To evaluate the efficacy and safety of oral ibrexafungerp (HS-10366) versus placebo in Chinese patients with vulvovaginal candidiasis (VVC). METHODS: A double-blind, placebo-controlled, randomized, multicenter phase III study was conducted in symptomatic VVC patients. Patients received (2:1) twice-daily oral ibrexafungerp 300 mg or matching placebo for 1 day. The primary endpoint was clinical cure (vulvovaginal signs and symptoms [VSS] score = 0) at test-of-cure (TOC) on day 11 ± 3...
April 3, 2024: Infection
https://read.qxmd.com/read/38567960/correction-for-choudhary-et-al-genome-wide-translational-response-of-candida-albicans-to-fluconazole-treatment
#33
JOURNAL ARTICLE
Saket Choudhary, Vasanthakrishna Mundodi, Andrew D Smith, David Kadosh
No abstract text is available yet for this article.
April 3, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38567615/analysis-of-candidemia-cases-in-a-city-hospital-during-the-covid-19-pandemic
#34
JOURNAL ARTICLE
O Ozalp, S Komec, M Unsel, A Gunduz, O Altuntas Aydin
OBJECTIVE: The frequency and mortality of candidemia remain important. Non-albicans Candida species such as C. auris are increasing. PATIENTS AND METHODS: A retrospective review of adult patients diagnosed with bloodstream infection due to Candida species in the 17 months between July 1, 2020, and December 1, 2021, was performed. Yeast colonies grown in culture were identified by matrix-assisted laser desorption/ionization time-of-flight. Antifungal susceptibility tests of Candida strains were performed with Sensititre YeastOne (TREK Diagnostic Systems Inc...
March 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38567576/in-vitro-antifungal-susceptibility-of-the-dermatophytes-a-single-center-study-from-eastern-black-sea-region-of-turkey
#35
JOURNAL ARTICLE
I D Oğuz, Ş Direkel, B Akşan, S Kulakli, S Aksoy
OBJECTIVE: A large number of patients applying to the dermatology clinics are affected by fungal diseases, and a significant portion of which are superficial fungal infections. Dermatophyte infections are a notable public health concern and frequently encountered in clinical practice. Dermatophytosis not only compromises the quality of life but also predisposes individuals to various comorbidities due to its role as a gateway for secondary bacterial agents. This study aims to determine the species distribution of dermatophytes prevalent and assess their susceptibility to antifungal drugs...
March 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38560676/formulation-and-evaluation-of-fluconazole-emulgels-for-potential-treatment-of-vaginal-candidiasis
#36
JOURNAL ARTICLE
Oriyomi Temitayo Ogedengbe, Oluwadamilola Miriam Kolawole
Localised treatment of vaginal candidiasis could improve the therapeutic outcomes of patients with vaginal candidiasis as well as reduce drug dosage and dosing interval. The aim of the research project was to develop fluconazole emulgel formulations, and evaluate their physicochemical, drug release, antifungal, safety, and stability profile, for potential treatment of vaginal candidiasis. Xanthan gum and HPMC E5LV-based fluconazole emulgels were prepared using the spontaneous emulsification method and their physicochemical properties, drug content, drug release profile, anti-fungal activity against Candida albicans , in vivo vaginal biocompatibility and stability profile were evaluated using standard protocols...
March 30, 2024: Heliyon
https://read.qxmd.com/read/38559327/pulmonary-cryptococcosis-suspected-due-to-inhalation-of-swallow-excreta-presenting-with-multiple-infiltrative-shadows
#37
Kei Kanata, Toshihiro Shirai, Yutaro Ito, Koshiro Ichijo, Masahiro Uehara
A 70-year-old woman had been treated with methotrexate for rheumatoid arthritis by a rheumatologist who opened a clinic near our hospital. In January of a certain year, she had respiratory symptoms of cough, sputum, and fever. Laboratory test results showed a white blood cell count of 8600/μL (neutrophil count of 5330/μL, lymphocyte count of 2490 μ/L), C-reactive protein (CRP) of 3.30 mg/dL. Chest radiography showed multiple infiltrative shadows in the right middle and lower lobes. Bronchoalveolar lavage fluid (BAL) lymphocyte count was increased (65...
2024: Respiratory Medicine Case Reports
https://read.qxmd.com/read/38553023/syndrome-of-inappropriate-antidiuretic-hormone-release-secondary-to-central-nervous-system-coccidioidomycosis-with-vasculitis
#38
JOURNAL ARTICLE
Gregory Lawrence Branigan, Hasan T Ozgur, James Lim, Talha Riaz
A man in his 60s presented to the clinic due to night sweats and weight loss following pneumonia. He was found to have hyponatraemia due to a syndrome of inappropriate antidiuretic hormone (SIADH). CT of the thorax was concerning for pulmonary nodules. He was ultimately diagnosed with pulmonary coccidioidomycosis (CM) and started on fluconazole 400 mg daily with improvement in symptoms. Due to the report of headaches, head MRI was conducted which suggested central nervous system (CNS) involvement. Cerebrospinal fluid analysis was consistent with CNS CM and head magnetic resonance angiography confirmed the presence of CNS vasculitis...
March 29, 2024: BMJ Case Reports
https://read.qxmd.com/read/38551121/the-sphingolipid-inhibitor-myriocin-increases-candida-auris-susceptibility-to-amphotericin-b
#39
JOURNAL ARTICLE
Hanna Stieber, Lara Junghanns, Hannah Wilhelm, Maria Batliner, Alexander Maximilian Aldejohann, Oliver Kurzai, Ronny Martin
BACKGROUND: The emergence of the pathogenic yeast Candida auris is of global concern due to its ability to cause hospital outbreaks and develop resistance against all antifungal drug classes. Based on published data for baker's yeast Saccharomyces cerevisiae, sphingolipid biosynthesis, which is essential for maintaining membrane fluidity and formation of lipid rafts, could offer a target for additive treatment. METHODS: We analysed the susceptibility of C. auris to myriocin, which is an inhibitor of the de novo synthesis of sphingolipids in eukaryotic cells in comparison to other Candida species...
April 2024: Mycoses
https://read.qxmd.com/read/38551114/patients-with-recurrent-vulvovaginal-candidiasis-exhibit-a-decrease-in-both-the-fungicidal-activity-of-neutrophils-and-the-proliferation-of-peripheral-blood-mononuclear-cells
#40
JOURNAL ARTICLE
Jeiser Marcelo Consuegra-Asprilla, Carolina Rodríguez-Echeverri, Daniela Herrera Posada, Beatriz L Gómez, Ángel González
BACKGROUND: Recurrent vulvovaginal candidiasis (RVVC) is an important and underestimated fungal infection. OBJECTIVE: We aimed to determine the fungicidal and proliferative capacities of neutrophils and peripheral blood mononuclear cells (PBMCs), respectively and the clinical and microbiological characteristics of a cohort of Colombian patients diagnosed with RVVC. METHODS: A cross-sectional study was conducted. A total of 66 women were included (40 diagnosed with RVVC and 26 healthy women [HW])...
April 2024: Mycoses
keyword
keyword
64790
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.